Last reviewed · How we verify
Duration of eradication regimen — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Duration of eradication regimen (Duration of eradication regimen) — Incheon St.Mary's Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Duration of eradication regimen TARGET | Duration of eradication regimen | Incheon St.Mary's Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Duration of eradication regimen CI watch — RSS
- Duration of eradication regimen CI watch — Atom
- Duration of eradication regimen CI watch — JSON
- Duration of eradication regimen alone — RSS
Cite this brief
Drug Landscape (2026). Duration of eradication regimen — Competitive Intelligence Brief. https://druglandscape.com/ci/duration-of-eradication-regimen. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab